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Abstract
Background: Pneumococcus kills over one million children annually and over 90 % of these deaths occur in
low-income countries especially in Sub-Saharan Africa (SSA) where HIV exacerbates the disease burden. In SSA,
serotype 1 pneumococci particularly the endemic ST217 clone, causes majority of the pneumococcal disease
burden. To understand the evolution of the virulent ST217 clone, we analysed ST217 whole genomes from
isolates sampled from African and Asian countries.
Methods: We analysed 226 whole genome sequences from the ST217 lineage sampled from 9 African and 4 Asian
countries. We constructed a whole genome alignment and used it for phylogenetic and coalescent analyses. We
also screened the genomes to determine presence of antibiotic resistance conferring genes.
Results: Population structure analysis grouped the ST217 isolates into five sequence clusters (SCs), which were
highly associated with different geographical regions and showed limited intracontinental and intercontinental
spread. The SCs showed lower than expected genomic sequence, which suggested strong purifying selection and
small population sizes caused by bottlenecks. Recombination rates varied between the SCs but were lower than in
other successful clones such as PMEN1. African isolates showed higher prevalence of antibiotic resistance genes
than Asian isolates. Interestingly, certain West African isolates harbored a defective chloramphenicol and tetracycline
resistance-conferring element (Tn5253) with a deletion in the loci encoding the chloramphenicol resistance gene
(catpC194), which caused lower chloramphenicol than tetracycline resistance. Furthermore, certain genes that
promote colonisation were absent in the isolates, which may contribute to serotype 1’s rarity in carriage and
consequently its lower recombination rates.
Conclusions: The high phylogeographic diversity of the ST217 clone shows that this clone has been in circulation
globally for a long time, which allowed its diversification and adaptation in different geographical regions. Such
geographic adaptation reflects local variations in selection pressures in different locales. Further studies will be
required to fully understand the biological mechanisms which makes the ST217 clone highly invasive but unable
to successfully colonise the human nasopharynx for long durations which results in lower recombination rates.
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Background
Streptococcus pneumoniae, (or ‘the pneumococcus’), is
a Gram-positive, α-hemolytic bacterium which is a
cause of significant disease morbidity and mortality
worldwide [1]. Invasive pneumococcal diseases (IPD)
causes ~1 million deaths in children less than 5 years
old every year [1] with the highest IPD burden i.e.
~90 % of the total global death toll, occurring in low-
income countries such as Sub-Saharan Africa, Latin
America and Asia [1, 2].
Nearly 100 pneumococcal serotypes have been re-
ported to date [3–9], which vary geographically in both
prevalence and distribution [2] and in their propensity
to cause IPD [10]. Serotype 1 ranks as one of the most
prevalent serotypes that cause IPD globally although it is
rarely isolated from nasopharyngeal carriage in humans
[10, 11], which results in high invasive potential with
odds ratio of ~10 for causing IPD relative to carriage
[10]. Longitudinal studies have reported that serotype 1
is carried for a period of ~9 days, which is the second
shortest human carriage duration reported to date after
serotype 33B [12]. Pneumococcal isolates undergo gen-
etic recombination where by competent isolates acquire
and incorporate external DNA into their chromosomes.
This occurs more efficiently during carriage than inva-
sive disease [13]. The rarity of serotype 1 isolates in car-
riage has led to the hypothesis it has a lower rate of
recombination due to limited opportunities for genetic
exchange during carriage [14]. A recent report has iden-
tified the presence of genetic recombination in a global
serotype 1 population [15].
Multilocus sequence typing (MLST) [16] and phylogen-
etic analysis of a global collection of serotype 1 isolates,
showed that serotype 1 isolates cluster into three distinct
clades predominantly associated with continent [17].
European and American isolates clustered into clades A
and C respectively, whilst clade B associated with African
isolates. Recently, using a whole genome phylogeny, we
have reported an additional clade named clade D, which
consisted of isolates from Asia [15].
Serotype 1 pneumococci cause a high IPD burden
especially in Africa [2] where it is endemic in most
countries particularly within the African Meningitis belt
[18]. The high burden led to the incorporation of sero-
type 1 capsular polysaccharides in the pneumococcal
conjugate vaccines (PCV); PCV10 [19] and PCV13 [20],
which have now been introduced globally. Currently,
studies to assess the effectiveness of PCV10 and PCV13
in the African population are underway. In Africa, the
majority of the serotype 1 IPD is caused by the ST217
clone (also known as Sweden1-27 (PMEN27) as defined
by the Pneumococcal Molecular Epidemiology Network)
[17]. This lineage accounts for over 95 % of serotype 1
IPD in Malawi and 98 % of such cases in South Africa
[21–23] and causes pneumococcal meningitis outbreaks
in West Africa [24, 25].
We have previously described the global population
structure of multiple serotype 1 STs [15]. In the present
study, we collected 226 ST217 serotype 1 isolates from
multiple African and Asian countries to gain further
insights into the biology of the clone. We used whole
genome sequencing to determine the population struc-
ture, genomic diversity, geographic spread, population
size changes through time and identify key pneumococ-
cal virulence genes associated with the ST217 endemic
virulent clone. Our findings provide further insights into
the biological mechanisms that may have driven the suc-
cess of the ST217 clone especially in Africa.
Methods
Isolate collection, DNA extraction and sequencing
We collected pneumococcal serotype 1 ST217 isolates
from 1994 to 2011. Isolates were obtained from both
carriage and invasive disease in individuals of all age
groups from hospitals in different countries collaborat-
ing in the Pneumococcal African Genomics (PAGe)
Consortium (http://www.pagegenomes.org) (Additional
file 1). The Global Pneumococcal Strain Bank at the
Centers for Disease Control and Prevention (CDC) pro-
vided additional isolates from additional nine countries.
In total, the study dataset comprised of 226 isolates; in-
vasive (n = 206), nasopharynx (n = 6) and other body
sites or unknown source (n = 15), from nine African
countries (n = 200) and four Asian countries (n = 26).
Because carriage of serotype 1 pneumococci is extremely
rare, the dataset constituted predominantly of invasive
isolates. Genomic DNA libraries were prepared from the
isolates and sequenced at the Wellcome Trust Sanger
Institute using Illumina Genome Analyzer II (Illumina,
CA, USA).
Detection of serotypes and sequence types
We subjected the isolates to molecular serotyping by PCR
[26]. The inferred serotypes agreed with in silico identified
serotypes using short read mapping against reference
capsule biosynthetic locus genes [27]. Sequence types
(STs) were determined using the pneumococcal multilo-
cus sequence typing (MLST) scheme [16, 28].
Recombination detection and phylogeny construction
We obtained consensus sequences for the study isolates
through mapping short paired-end sequence reads
against a published serotype 1 reference whole genome
sequence (Spn1041) [Genbank: CACE00000000] using
SMALT v0.7.4 (http://www.sanger.ac.uk/resources/soft-
ware/smalt/). To realign the insertion and deletion
(indel) sites, we used GATK v3.3.0 [29]. From the rea-
ligned mapping files, we generated consensus whole
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genome sequences, which were aligned to generate whole
genome alignment. We identified sequence clusters (SCs)
for the study isolates using the whole genome sequence
alignment generated as described in the previous section.
Following this, we generated an alignment of only the
polymorphic (variable) sites using Snp-Sites [30]. The hier-
BAPS module in the BAPS v6.0 s software clustered the
isolates into unique subpopulations or SCs [31, 32]. We
detected recombination events for each SC whole genome
alignment using Gubbins v1.1.1 [33] and inferred the
maximum likelihood phylogeny using RAxML v7.0.4
using a generalised time reversible (GTR) model with
Gamma heterogeneity among nucleotide sites [34] and
100 bootstrap replicates. Closely related serotype 1 ST615
isolates were included in the alignment and later used to
root the phylogeny as an outgroup. The tree visualisations
were done using BioPython [35] and iToL v3.2.4 [36]. The
sequence reads were also assembled into contigs using an
automated sequence assembly pipeline developed at the
Wellcome Trust Sanger Institute [37] that uses Velvet
v1.2.09 [38], SSPACE Basic v2.0 [39] and BWA v0.7.12-
r1039 [40]. The assembled genes were annotated using
Prokka v1.11 [41] and core and accessory genome analysis
was done using Roary [42].
Within-sequence cluster genetic diversity
We calculated the pairwise distances between isolates
in the phylogeny and the terminal branch distances in
the phylogeny using BioPython [35], Phylobase and
Phytools packages in R [43]. Additional evolution parame-
ters namely the number of segregating or polymorphic
alignment sites (S), proportion of polymorphic sites (Ps),
observed nucleotide sequence diversity (π), expected nu-
cleotide sequence diversity (Θ) and Tajima’s D, which is
the scaled difference of π and Θ, were inferred using
MEGA v6.0 [44].
Most recent common ancestors and mutation rates
We used Path-O-Gen v1.4 to investigate the temporal
evolution patterns within the inferred SCs (http://tree.
bio.ed.ac.uk/software/pathogen/). Coalescent analyses were
done using BEAUti v1.7.5 and BEAST v1.8 [45, 46] with
the following parameter specifications; lognormal relaxed
uncorrelated clock model [47], constant size coalescent
tree prior, Hasegawa-Kishino-Yano (HKY85) nucleotide
substitution model with estimated base frequencies [48]
and a Gamma (Y) site heterogeneity model with 4 rate
categories [49] and the prior mutation rate (μ) from a
previous study [50]. 200,000,000 Markov Chain Monte
Carlo (MCMC) iterations were performed and sampled
every 5000 steps with a burn-in of 20,000,000 iterations
discarded from each independent MCMC analysis. We
resampled the MCMC runs at 20,000 steps using Log-
Combiner v1.7.5 (http://beast.bio.ed.ac.uk/logcombiner)
to estimate the mean values and 95 % highest posterior
densities (HPD) for different parameters of interest in
Tracer v1.6 (http://beast.bio.ed.ac.uk/tracer) [51]. The
relative genetic diversity over time or the effective
population size (Neτ), was estimated using BEAST with
a Bayesian skyline plot (BSP) model with 10 groups and
a piecewise constant skyline model variant [52].
Presence of virulence and antibiotic resistance genes
We determined pneumococcal virulence genes from the
published studies [53] and obtained the sequences for
each virulence gene from the Virulence Factors Database
[54] while antibiotic resistance conferring genes and inte-
grative conjugative elements (ICEs) transposons were ob-
tained from Genbank [55]. We checked the presence and
absence of the virulence genes and the resistance elements
using nucleotide BLASTN v2.2.30 [56]. To determine the
presence of a genomic feature, we considered only the
highest scoring pairs (HSPs) from BLAST comparisons
with an E-value less than 1E-3. Such HSPs represented
significant sequence matches and were joined. We consid-
ered the feature present when the combined HSPs cov-
ered at least 70 % of the query feature sequence and
showed at least 80 % nucleotide identity. We visualised
the BLAST comparisons using ACT v13.0.0 [57]. To valid-
ate the absence of genomic features, we used mapped
short sequence reads against reference features using
BWA v0.7.12-r1039 [40].
Statistical analysis
All tests were performed using R v3.1.2 (R Core Team)
and GraphPad Prism v6.0 (www.graphpad.com). We
checked conformity of the observations to the standard
normal (Gaussian) distribution using the Shapiro-Wilk
and Kolmogorov-Smirnov tests and compared differ-
ences between multiple groups with small sample sizes
using the Kruskal-Wallis test otherwise analysis of
variance (ANOVA) and unpaired Student’s t tests were
used. We compared differences in proportions using
the two-tailed two-sample proportions test with a Yates
continuity correction.
Results
Phylogenetic clusters and geographic structure
Phylogenetic analysis of the 226 ST217 isolates from
Africa (n = 200) and Asia (n = 26) clearly showed five dis-
tinct clades (Fig. 1a and b). We identified the underlying
genetic population structure of the isolates by clustering
the isolates into genetically distinct subpopulations known
as sequence clusters (SC). The identified SCs matched the
phylogenetic clades from the phylogeny in Fig. 1 which
was constructed from a recombination free alignment.
The identified SCs predominantly associated with geo-
graphical origin of the isolates and were named to reflect
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the origin as follows SC1-SA, SC2-WA, SC3-SEA, SC4-
AS and SC5-AS. The suffix denotes the origin of the ma-
jority isolates in the SC where SA denotes South Africa,
WA denotes West Africa, SEA denotes South East Africa
and AS denotes Asia. Almost half the samples fell into
SC3-SEA (n = 110), with SC1-SA (n = 58), and SC2-WA
(n = 53) accounting for the majority of the remaining sam-
ples. Both country and continent of origin of the isolates
associated with the SCs (p < 0.0001). Except for two
instances where isolates from South Africa (n = 2) and
Mozambique (n = 1) were identified in the West African
clade as intracontinental clonal spread, all the isolates
from southern Africa, which together represent the
best-sampled region in the analysis, fell into clades
SC1-SA and SC3-SEA. Clade SC1-SA predominantly
comprised of South African isolates with a few from
Mozambique that spread from South Africa, while
clade SC3-SEA comprised of isolates from Malawi and
Mozambique with a few isolates from South Africa and
The Gambia. The West African clade showed highest
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Fig. 1 Phylogenetic relationships of the ST217 serotype 1 isolates. a Maximum likelihood phylogeny showing genetic relationships of the ST217
isolates rooted using isolates from ST615 as an outgroup (not shown). The colored strips after the phylogenetic tips shows the inferred SCs,
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geographical distribution and consisted of isolates from
both Africa and Asia. The remaining two smaller Asian
SCs contained few isolates but showed a clear associ-
ation with Middle East countries and their deep
branching suggests ancient divergence maintained by
geographic separation.
Geographical spread of the ST217 clone
The association of some SCs such as the West African
clade with multiple continents and the association of
some countries with multiple SCs suggested geograph-
ical spread of the clone between regions (Fig. 1c and d).
Further analysis of the intermixing of the isolates in the
SCs and genetic relatedness based on the phylogenetic
branch lengths allowed for inference of the potential
spread of the ST217 clone between countries and conti-
nents. Overall, closely located countries shared closely
related but genetically distinguishable isolates with few
mutations separating them. In some instances, isolates
from one country clustered on a different branch with
isolates from a different country. Such patterns allowed
for determination of the not only occurrences and where
applicable the directionality of the spread of the clone.
For example, four instances of spread were identified in
the typically South African clade (SC1-SA) whereby
isolates spread from Mozambique grouped with South
African isolates but not the rest of the Mozambican iso-
lates in clade SC3-SEA, which demonstrates a spread
from South Africa to Mozambique where they were
eventually sampled (Fig. 1a and Additional file 2a).
Although clade SC3-SEA was typically Malawian and
Mozambican isolates, isolates from each country formed
very tight genetically related but distinct clusters in the
SC. In depth analysis of this clade showed that some
Mozambican isolates clustered with the Malawian iso-
lates within the clade, which suggest very recent and
short-range spread between these closely located coun-
tries. We also identified several long-range intraconti-
nental and intercontinental spread of the clone. Spread
of isolates from West Africa to Mozambique and South
Africa (Additional file 2b) and spread from Malawi to the
Gambia in SC3-SEA provides examples of such long-
range intracontinental spread events (Additional file 2c).
On the other hand, the clustering of Asian isolates with
the West African counterparts in clade SC2-WA clearly
demonstrates intercontinental spread of the clone.
Distribution of alleles in sequence clusters
Differences between the three largest SCs in terms of
sequence variation were evident from the branch lengths
in Fig. 1. We calculated the cophenetic distances between
pairs of isolates in each SC, terminal taxon tip branch
lengths in the phylogeny and the distribution of SNPs in
each subpopulation to precisely quantify the within and
between SC sequence variation and diversity (Fig. 2a-b
and Additional file 3). The mean cophenetic distances
were significantly different between the three SCs (p <
0.0001). Clade SC3-SEA showed the lowest mean
cophenetic distance (mean = 97.35) followed by clade
SC1-SA (mean = 167.90). On the other hand, clade
SC2-WA (mean = 721.1) showed the highest cophenetic
distance, which reflects the greater geographical diver-
sity in this SC. Furthermore, clade SC2-WA showed
longer terminal branches than SC1-SA (p < 0.0001) and
SC3-SEA (p = 0.003), which suggest higher mutation
rates in the West African SC. Although SC1-SA showed
slightly longer tip distances than SC3-SEA, no signifi-
cant differences (p = 0.636) were observed. Our findings
indicate that the ST217 isolates from West Africa show
higher sequence diversity than isolates from Southern
African region whereby the observed lower diversity
maybe a consequence of recent introduction or potentially
small population sizes due to population bottlenecks.
Temporal evolution of the ST217 sequence clusters
To understand the changes over time in the ST217 SCs,
we studied sequence variation over the sampling period
(1994 to 2011). Horizontally acquired mutations were
removed to study ancestral changes alone [33]. We
checked the SCs for molecular clock-like evolution de-
termined as significant linear accumulation of mutations
with time. This was done using a linear regression ana-
lysis of the phylogenetic root-to-tip distances and the
isolation years for the isolates. We observed a significant
relationship in clades SC1-SA (R2 = 0.1176, p = 0.0084)
and SC3-SEA (R2 = 0.5530, p < 0.0001) but not clade
SC2-WA (R2 = 0.0079, p = 0.548) (Fig. 2c). The lack of
molecular-clock-like evolution in clade SC2-WA, which
showed the highest diversity in terms of both sequence
variation and geographical origin and suggests that dee-
per sampling is required to study this SC.
From the regression of the root-to-tip distance and
isolation years, we calculated mutation rates (μ) of 1.12 ×
10-6 and 1.01 × 10-6 nucleotide substitutions per site per
year for SC1-SA and SC3-SEA respectively (Fig. 2c). The
estimates from BEAST [45, 46] were consistent with the
regression analysis and showed mutation rates of 2.05 ×
10-6 and 4.58 × 10-6 nucleotide substitutions per site per
year for SC1-SA and SC3-SEA respectively. Such mutation
rates suggest introduction of approximately 4 to 10 nu-
cleotide changes per isolate annually. To determine the
potential dates of emergence or importation of the SCs,
we extrapolated the fitted linear regression backwards to
determine the time corresponding to zero phylogenetic
root-to-tip distance, which represents the time of diver-
gence of the most recent common ancestor (TMRCA).
The TMRCAs for the clades SC1-SA and SC3-SEA dated
to 1981 (95 % CI: 1912 to 1992) and 1990 (95 % CI: 1987
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to 1993) respectively (Fig. 2c). However, TMRCA esti-
mates from BEAST were slightly different to the ex-
trapolated regression estimates, with 1990 for SC1-SA
(95 % highest posterior density (HPD): 1981 to 1998)
and 1955 for SC3-SEA (95 % HPD: 1923 to 1979).
Nevertheless, both methods unequivocally suggest re-
cent emergence of the SCs with TMRCAs dating back
to the last century. In terms of the population sizes and
population dynamics, Bayesian skyline plots (BSP)
showed that the relative genetic diversity which corre-
sponds to the effective population size (Neτ), increased
rapidly in the early 1990s for SC3-SEA possibly follow-
ing its emergence and was higher than in SC1-SA
(Fig. 2d). However, the effective population size in SC3-
SEA decreased slightly from the mid-2000s but
remained relatively stable but slightly lower than in
SC1-SA until the last sampling point in 2010 consistent
with the findings in Fig. 2a-b.
Genetic recombination in the ST217 sequence clusters
We observed the distribution of genetic recombination
events consistent with previous studies [15, 50, 58]. The
mean sizes of the recombination events varied signifi-
cantly (p < 0.0001) between the SCs and the mean sizes
ranged from 4650 bp to 75156 bp (Table 1). The ratio of
number of single nucleotide polymorphisms (SNPs)
imported by recombination to those arising independently
in the non-recombining regions (r/m) did not vary sig-
nificantly between the ST217 SCs (p = 0.278) (Table 1).
SC2-WA showed highest relative rate of recombination
(r/m = 4.22) followed by SC3-SEA (r/m = 1.51) while
SC1-SA (r/m = 0.05) showed the lowest recombination
(Additional files 4, 5 and 6). The mean number of dis-
tinct recombination events in each SC per isolate
ranged from 0.86 to 2.2 and up to 96 % of the isolates
shared some recombination events. Surface proteins,
antibiotic resistance and mobile elements were also
1980 2000 2010
0
50
100
150
Date of Isolation (Year)
R
oo
t-
to
-T
ip
 D
is
ta
nc
e
t M
R
C
A
 =
19
81
1990
t M
R
C
A
 =
19
90
1980 2000 20101990
100
101
102
103
R
el
at
iv
e 
G
en
et
ic
 
D
iv
er
si
ty
Date of Isolation (Year)
P
ai
rw
is
e 
D
iff
er
en
ce
 
(×
10
2 )
0
1
2
3
SC1 SC2 SC3
Sequence Cluster (SC)
0 50 100 150
0
2
4
6
8
10
Isolate
T
ip
 D
is
ta
nc
e 
(1
0-
3 )
c
a
d
b••••
••••••••
SC1-SA SC2-WA SC3-SEA
Sequence 
Cluster (SC)
Fig. 2 Estimated evolution parameters in the ST217 SCs. Distribution of a cophenetic distances between pairs of the ST217 isolates in each SC
and b Terminal phylogenetic branch lengths for the isolates in the clades. c Graph showing relationship between the phylogenetic root-to-tip
distances and isolation years of the isolates for each clade: SC1-SA (blue), SC2-SA (light red) and SC3-SEA (green). Isolates in clade SC2-SA showed
no evidence of molecular clock-like evolution and was not subjected to coalescent analysis. d Bayesian skyline plot showing the temporal effective
population sizes (Neτ) of clades SC1-SA and SC3-SEA. P-values are shown as follows: p ≤ 0.05 (•), p ≤ 0.01 (••), p ≤ 0.001 (•••), p ≤ 0.0001 (••••)
and p > 0.05 (ns)
Table 1 Summary of the identified recombination events in the ST217 isolates in each SC
Clade NREC
a Recombination Size (bp) Recombination to Mutation (r/m) SNPs per Recombination Event
Lower 95 % CI Mean Upper 95 % CI Lower 95 % CI Mean Upper 95 % CI Lower 95 % CI Mean Upper 95 % CI
SC1-SA 92 1736 4650 7565 0 0.05 0.12 0 24.80 57.67
SC2-WA 86 50111 75156 100201 0 4.22 7.80 102.20 348 593.90
SC3-SEA 61 12 21149 9490 0 1.51 2.72 48.00 176.40 304.70
CI designates confidence intervals
aThe number of recombination events identified in each clade in designated by NREC
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common in the ‘hotspots’ of recombination as previ-
ously reported [15] (Additional files 7, 8 and 9). The
findings showed lower recombination rates in the
ST217 SCs than other successful pneumococcal clones
such as Spain23F-1 (PMEN1, r/m = 7.2) [50], Spain6B-2
(PMEN2, r/m = 14.9) [59] and Taiwan19F-14 (PMEN14,
r/m = 21.8) clones [59] but higher than the ST180 clone
(r/m = 0.07) [60].
Natural selection in genes
Comparing observed and expected number of SNPs re-
vealed potential dominant selective forces acting on the
genomes (Additional files 10). From the genome wide se-
quence alignment, we estimated a probability of ~0.012
for random occurrence of a single SNP at any position.
Using this probability, we calculated the expected occur-
rences of SNPs for every gene and compared this to the
observed number of SNPs form an alignment of each
gene. Approximately 15 % of the genes showed higher
number of SNPs than expected possibly due to diversify-
ing or balancing selection (Fig. 3). On the other hand, ~44
and ~40 % of the genes showed evidence of purifying se-
lection and neutral evolution. The higher number of genes
under purifying selection than diversifying selection sug-
gests that most genomic changes are either highly adap-
tive and strongly selected for or highly deleterious and
negatively selected for. Examples of genes under purifying
selection included the capsule biosynthesis genes while
phage and transposon elements were under diversifying
selection although the later may be driven by independent
phage evolution rather than pneumococcal evolution.
These findings suggest purifying selection and neutral
evolution are dominant forces driving the evolution of the
genes in the ST217 clone.
Colonisation and adherence factors
We also investigated the distribution of key pneumococ-
cal virulence factors in the ST217 clone (Additional file
9). There was near universal presence of the key viru-
lence genes in the ST217 isolates (Additional file 9).
These included surface exposed proteins such as autoly-
sins and choline binding proteins (CBPs); competence
proteins such as the competence stimulating peptides
(CSP), mismatch repair genes, two-component system
(TCS) genes and several others were universally present
in the isolates. All the isolates lacked the psrP gene,
which encodes an adhesin and facilitate biofilm forma-
tion [61], iga gene which encodes an immunoglobulin
protease that cleaves the human Iga and promote colon-
isation [62], two zinc metalloproteinase genes namely
zmpB and zmpC, important for colonisation [62] and
both pilus operons (type I or II) which promote adher-
ence to the epithelial surfaces [63–65] were also absent
in all the study isolates (Additional files 11 and 12). The
absence of the well-known adherence and colonisation
factors may not be the sole cause but may contribute to
the rarity of serotype 1 pneumococci in human nasopha-
ryngeal carriage which would in turn limit its opportun-
ities for recombination.
Accessory genes and antibiotic resistance conferring
elements
We identified 1520 core genes present in at least 99 % of
the isolates and an overall gene repertoire of 4594 genes.
Majority of the accessory genes were shared between
isolates in the same SCs (Additional file 13). In terms of
antibiotic resistance, the Tn5253 integrative conjugative
element (ICE) harbored both tetM and catpC194 genes
which encodes proteins conferring resistance to tetracyc-
line and chloramphenicol antibiotics (Fig. 4). Further-
more, macrolide resistance conferring ICEs that carry
the ermB and mefA/E genes were absent. Overall, African
isolates showed a higher prevalence of the Tn5253 elem-
ent than the Asian ST217 isolates (Fig. 5a).
Within the West African clade (SC2-WA) prevalence
of tetM gene was higher than catpC194 gene despite both
genes being harbored on only Tn5253 element in this
population (Fig. 5b). We did not observe such a disparity
in the Asian isolates of the genetic background in the
clade, which showed equal prevalence of both genes. Be-
cause no additional ICEs were identified that carried
additional tetracycline resistance genes, we checked
whether there was either high sequence diversity in the
catpC194 gene, which would make it difficult to detect it
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Fig. 3 Distribution of the single nucleotide polymorphisms (SNPs) in
the genes identified in the ST217 isolates. Boxplot showing the
observed (OSNP) and expected (ESNP) number of SNPs identified in
each gene in the ST217 isolates. Genes with log2 (OSNP/ESNP) less
than -1 were considered to be under ‘negative selection’, greater
than 1 under ‘positive selection’ and under ‘neutral evolution’ for
those between -1 and 1
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or whether the catpC194 gene was completely deleted from
the Tn5253 element in the chloramphenicol susceptible
but tetracycline resistant isolates. These isolates harbored
a defective Tn5253 ICE with an intact tetM gene but with
an ~5Kb deletion across the pC194 plasmid loci that en-
codes and harbors the catpC194 gene (Figs. 4, Fig. 5c). To
confirm the deletion of the chloramphenicol resistance
gene from Tn5253 element, we mapped the short se-
quence reads from isolates containing deleted loci against
a reference Tn5253 sequence with an intact chloram-
phenicol resistance conferring loci. Consistent with the
previously mentioned results, we observed no read map-
ping across the pC194 plasmid (Fig. 6). Furthermore, we
observed no mapping on the phage attachment site (attL),
excisionase (xis) and integrase (int) genes in the Tn5253
element. Overall, 68.75 % of the West African ST217
isolates carried the Tn5253 element without chloram-
phenicol resistance gene and in comparison 5.17 % of the
South African isolates in clade (SC1-SA) and none in the
South Eastern African clade (SC3-SEA) carried the defect-
ive element (Fig. 5d).
Discussion
IPD due to serotype 1 pneumococcus in Sub Saharan
Africa is predominantly caused by the endemic ST217
clone. Our pneumococcal population genomic dataset of-
fers a unique opportunity for understanding how this
clone has evolved and spread across and outside the con-
tinent. Our findings showed evolution of the ST217 clone
into geographically distinct lineages with different charac-
teristics. Previous studies have shown that serotype 1 is
highly clonal [17] and exhibits strong phylogeographic
Fig. 4 Distribution of antibiotic resistance conferring genes and elements in the ST217 isolates. The columns to the right of the phylogeny show
presence and absence of the antibiotic resistance conferring elements and presence of the deletion in the region containing chloramphenicol
resistance gene
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structure [15]. These characteristics may allow for accur-
ate inference of recent spread of the ST217 clone between
countries. Our findings show with higher genomic reso-
lution the recent spread of the ST217 clone. We identified
both short-range and long-range transmission of the clone
within closely located African countries and between West
Africa and Southern Africa and between West African
and Asia. In most instances we were able to establish the
direction of spread of the clone between countries, but in
others we were only able to detect potential spread of the
ST217 clone without inferring the directionality. Never-
theless, our findings show the intracontinental and
intercontinental spread of the ST217 clone with high
resolution using whole genome sequencing.
The ST217 SCs restricted to different geographical
regions may experience different selective pressures. Our
findings showed consistently lower than expected amount
of polymorphism under the mutation drift equilibrium.
All the lineages showed negative estimates for the Tajima
D statistic which suggested genome-wide selective sweeps
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and potentially population bottlenecks such as those that
would be expected to accompany periodic epidemic waves
[66]. Temporal coalescent divergence dating using isola-
tion years and phylogenies revealed recent emergence of
the SCs. The typically South Eastern Africa clade (SC3-
SEA) and the Southern African clade (SC1-SA) emerged
in the 1980s and the early 1990s respectively while the
emergence of the West African clade (SC2-WA) could
not be fully determined because of the lack of the molecu-
lar clock signal or linear evolution with time in this clade.
Overall, our findings clearly suggest recent emergence and
clonal expansion of the ST217 in SSA countries within the
last century. In the South Eastern African clade, the rela-
tive genetic diversity or the effective population size (Neτ)
of the lineage, increased rapidly in the 1990s until early
2000s followed by a decline around 2005. The skyline plot
suggests that the population then remained stable until
the last sampling point in 2010, but this must be treated
with caution because of the possibility that in this more
recent time period, the relatively scant data leads the ana-
lysis to recover the prior [66]. The decline in the popula-
tion size in clade SC3-SEA coincided with the previously
reported decline in IPD in Malawi after scale-up of anti-
retroviral therapy and cotrimoxazole prophylaxis [67]. In
the South African clade, the population size increased
slowly from late 1990s and has consistently remained
higher than in Malawi and Mozambique from mid-2000s
until 2010, possibly reflecting the higher diversity of the
South African population. In addition, the observed
mutation rates in both clades were similar to previously
published estimates which further suggests that differ-
ences in recombination rather than mutation rates
drive variations in genetic diversity between pneumo-
coccal lineages vary [68].
Serotype 1 pneumococci are rarely detected in carriage
and our study provides an additional explanation for
this. We show that certain key pneumococcal loci im-
portant for nasopharyngeal colonisation are absent from
ST217 isolates including the pneumococcal pilus operon
genes, psrP, iga, zmpB and zmpC. These genes promote
adherence to the epithelial surfaces as adhesins [62–64,
69–71]. Of particular interest was the iga gene, which
encodes a protein that cleaves human IgA1 protease and
facilitate colonisation [62]. To determine the distribution
of the absent genes in other pneumococcal lineages, we
screened the genes in isolates from Massachussetts
population [58]. Overall, both pilus operon genes, psrP,
iga, zmpB and zmpC were present in between 5 and
20 % of the dataset suggesting that while these genes
may indeed promote colonisation, they cannot fully ex-
plain serotype 1’s absence in carriage compared to other
lineages because they were present in other lineages car-
ried for longer durations than serotype 1. Interestingly,
in the Massachusetts dataset, the pilus associated with
highly carried lineages such as serogroup 6, 19 F and
35B while iga associated with lineages containing sero-
types such as 11A, 15A,19A and 35 F and non-typeable
pneumococci. On the other hand, psrP was sporadically
distributed across various lineages in the Massachusetts
dataset but was completely absent in serotype 1. Major-
ity of the virulence genes such as pneumolysin (ply),
choline-binding proteins such as cbpA, competence
genes (comA-E), and neuraminidases (nanA and nanB)
and various cell surface antigens such as psaA-C were
ubiquitous in serotype 1 [53]. This is unsurprising be-
cause serotype 1 isolates are well-known for its high in-
vasive capacity and inability to efficiently colonise the
nasopharynx and sustain long durations of carriage.
Such inability to colonise humans may be primarily a
consequence of its polysaccharide capsule characteris-
tics, which elicits phagocytic killing and rapid clearance
[72] but the absence of the genes important for colonisa-
tion such as iga may also contribute to this effect. In
turn, this may limit serotype 1’s exposure to potential
donors of DNA thus causing the observed lower rates of
recombination since recombination occurs efficiently
during carriage [13, 73]. However, to validate this hy-
pothesis, further in vitro and in vivo studies are required
to determine the biological functions and pathways af-
fected by the absent genes and the role of the capsule
with regards to clearance by the immune system.
Occurrence of recombination events has been previ-
ously associated with acquisition of antibiotic resistance
as such lower rates of recombination may have conse-
quences in acquisition of the antibiotic resistance genes
[74]. The South African clade (SC1-SA) contained the
lowest amount of recombination and showed virtually
no acquisition of the antibiotic resistance conferring ele-
ments compared to other SCs. This may have driven the
lower acquisition of antibiotic resistance conferring mo-
bile genetic elements in this population and lineage as
evidenced by the lower (~27 %) resistance to tetracycline
and chloramphenicol, which is among the lowest for this
clone in Sub Saharan Africa [75]. On the other hand, no
macrolide resistance conferring elements were identified
in all the SCs, which is reassuring and suggests that
macrolides may still be a preferable choice of treatment
for the foreseeable future in patients infected with this
clone. Clades SC2-WA, which predominantly comprised
of West African isolates and clade SC3-SEA predomin-
antly consisting of isolates from Southern East African
countries such as Malawi, showed higher recombination
rates and antibiotic resistance particularly for chloram-
phenicol and tetracycline. Interestingly, the observed
higher resistance to tetracycline was much higher than
to chloramphenicol in the West African lineage despite
the presence of only Tn5253 element which carries re-
sistance conferring genes for both antibiotics [76]. This
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observation was consistent with previous study from the
Gambia, which also reported such a discrepancy using in
vitro phenotypic data [77]. Because resistance to both
antibiotics was due to the presence of only the Tn5253
element, this suggested that the chloramphenicol resist-
ant isolates contained a deletion of the chloramphenicol
resistance encoding loci. Interestingly, further compara-
tive genomic analysis of the tetracycline resistant but
chloramphenicol susceptible isolates revealed that these
isolates harbored a defective Tn5253 element with an in-
tact tetracycline resistance conferring gene (tetM) and a
large genomic deletion (~5Kb) across the pC194 plas-
mid, which harbors the chloramphenicol resistance con-
ferring gene (catpC194). We confirmed this deletion by
mapping raw reads from the isolates with the putative
deletion against an intact Tn5253 reference sequence.
However, Asian isolates in the West African clade, which
represented intercontinentally spread isolates from West
Africa, contained an intact Tn5253 element despite hav-
ing the same genetic background. This further suggests
that the deletion of the chloramphenicol resistance en-
coding loci was restricted to the West African isolates.
These findings explain why ST217 isolates from West
Africa are more susceptible to chloramphenicol than
tetracycline as previously reported [77].
However, an important yet unanswered question con-
cerns what may have driven the loss of chloramphenicol
resistance in the West African isolates but not Asian iso-
lates of the same genetic background. Further analysis of
previously published serotype 1 STs [15] showed that
the deletion of the chloramphenicol gene was not re-
stricted to only ST217 clone. Other closely related STs
from West Africa such as ST303, which were single
locus variants of the ST217 clone also showed wide-
spread deletion of the chloramphenicol resistance con-
ferring loci. This further suggests that the deletion was
not recent and if it was recent it would imply that the
defective Tn5253 has spread at a high rate possibly as a
consequence of selection in West Africa. During the
sampling period, chloramphenicol was widely used in
The Gambia [77] and possibly other West African coun-
tries while its use decreased in Southern African coun-
tries such as Malawi where all the resistant isolates
harbored an intact Tn5253 element. This may suggest
that the observed widespread loss of chloramphenicol
resistance mechanism in West African isolates may not
be a consequence of low chloramphenicol usage.
Conclusions
A potential limitation although not a concern for our
study may be uneven number of ST217 isolates sampled
from different countries, which does not imply higher in-
cidence in some countries. Such differences are primarily
because of deeper sampling in some countries. To avoid
biases, we primarily focused our analysis based on the SCs
rather than comparing their country-specific prevalence.
Nevertheless, our study provides a comprehensive gen-
omic portrait of the evolutionary dynamics of the hyper
virulent ST217 serotype 1 clone. Overall we have demon-
strated high genomic diversity and geographic structure of
the clone, which despite recent emergence of the common
ancestors for the SCs, suggests divergence of the clone
into multiple SCs in the distant past evidenced by the
deep branching between the SCs. Such geographical diver-
sification of the SCs also reflects adaptations to local
natural selective pressures. The higher acquisition of anti-
biotic resistance conferring elements in African isolates
may explain why the ST217 clone has been remarkably
successful in this continent despite spread of the clone to
other continents. In West Africa, majority of the isolates
harbour the defective Tn5253 conjugative element with a
large deletion in the locus harboring chloramphenicol re-
sistance conferring gene but it still remains to be deter-
mined what may have driven the spread of this defective
element in this region. The absence of certain genes
known to promote nasopharyngeal colonisation may
partly contribute to the rarity of serotype 1 during carriage
in additional to its capsule, which is a major virulence fac-
tor. Such rarity in carriage may explain the observed lower
recombination rates in the SCs compared to other globally
successful clones such as PMEN1. However, additional in
vivo and in vitro experiments coupled with whole genome
sequencing are required to provide further insights into
the biology of serotype 1 isolates.
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